Case serie...
Internal Medicine
2021-06-23

Case series describe reports of Guillain-Barré syndrome following receipt of ChAdOx1-S/nCoV-19 vaccine

In 2 case series published in the Annals of Neurology, researchers in India and the UK reported cases of Guillain-Barré syndrome (GBS) after individuals were vaccinated against coronavirus disease 2019 (COVID-19) with the ChAdOx1-S/nCoV-19 (AstraZeneca) vaccine. In the first case series, researchers led by Boby Varkey Maramattom, MD, Aster Medcity, Kerala, India, observed 7 cases of GBS that occurred within two weeks of the first dose of vaccination. All patients progressed to areflexic quadriplegia and 6 of the 7 patients required mechanical ventilation for respiratory failure.  Further...

Study sugg
Internal Medicine
2021-06-21

Study suggests convalescent plasma therapy associated with survival benefit in patients with he...

Findings from a study published in JAMA Oncology suggest a potential survival benefit in the adminis...

Risk of cl
Internal Medicine
2021-06-18

Risk of clinically relevant hyperglycemia with metoprolol compared to carvedilol in older adult...

BACKGROUND Although prior literature suggests that metoprolol may worsen glucose control compared to...

Videos from category: Cardiology

Effectiven
4:27

Effectiveness and safety of apixaban versus warfarin in obese patients with nonvalvular atrial fibrillation enrolled in medicare and veteran affairs

ACC 2021
PRADA Tria
4:48

PRADA Trial: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol

ACC 2021
ADAPTABLE
5:09

ADAPTABLE Study: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial

ACC 2021
Inspiratio
7:46

Inspiration-S Double Blind Randomized Controlled Trial: Atorvastatin Versus Placebo In Critically-ill Patients With Covid-19

ACC 2021

Videos from category: Dermatology

Psoriasis
6:51

Psoriasis is a systemic disease

EADV 2020
New non-al
6:36

New non-allergenic, anti-inflammatory fragrance could be game changer for dry skin sufferers

EADV 2020
New Resear
4:08

New Research Reveals that Risky Sexual Behaviour and STIs are on the Rise Despite COVID-19 Pandemic

EADV 2020
New eviden
7:47

New evidence shows that systemic inflammation in psoriasis can be treated orally with a non-living strain of a commensal microbe

EADV 2020

Videos from category: Diabetology

Accumulate
8:58

Accumulated CV data from SGLT2i outcomes trials

EASD 2020
Remission
10:22

Remission of type 2 diabetes with return of insulin secretory function restores normal pancreas morphology

EASD 2020
Summary of
7:44

Summary of clinical and scientific topics discussed at EASD 2020 congress

EASD 2020
Effects of
11:28

Effects of empagliflozin on physical activity and compensatory appetite responses in people with type 2 diabetes: the SEESAW trial

EASD 2020

Videos from category: Gastroenterology

Duodenal m
11:01

Duodenal mucosal resurfacing shown to discontinue insulin treatment in majority of type 2 diabetes patients and aid weight loss

UEG 2020
Allergy-re
7:48

Allergy-related diseases and IBS

UEG 2020
How to seq
2:20

How to sequence advanced therapies in IBD

ECCO 2020
A Next-Gen
3:06

A Next-Generation, Dual-Action Anti-Integrin Therapy for IBD

ECCO 2020

Videos from category: Hematology

Treatment
9:31

Treatment of hematological malignancies in 2021

EHA 2021
Harnessing
10:06

Harnessing the immune system in multiple myeloma: CAR T-cell therapy and bispecific antibodies

EHA 2021
Novelties
13:14

Novelties in the treatment of follicular lymphoma

EHA 2021
Novelties
10:59

Novelties in the treatment of chronic myeloid leukemia

EHA 2021

Videos from category: Internal Medicine

Which are
4:59

Which are the most promising new medications in phase 3 clinical trials for the treatment of painful large joint arthritis?

PAINWeek 2020
What is th
14:04

What is the role of transdermal fentanyl patches in management of cancer pain?

PAINWeek 2020
Optimising
8:42

Optimising the monitoring and treatment of SSc-ILD

EULAR 2020
Cardiovasc
7:42

Cardiovascular risk factors

ESH 2019

Videos from category: Oncology

State of t
17:17

State of the art treatment of breast cancer

ASCO 2021
Response a
6:58

Response and survival results up to five years from the KEYNOTE-052 phase 2 study

ASCO 2021
Expanded e
6:07

Expanded efficacy and safety analyses from CheckMate 577

ASCO 2021
Relatlimab
6:55

Relatlimab plus nivolumab versus NIVO in first-line advanced melanoma: Primary phase III results from RELATIVITY-047

ASCO 2021

Videos from category: Psychiatry

Novel Phar
8:13

Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder

EPA 2021
Meeting th
15:41

Meeting the challenges of schizophrenia care during the COVID-19 pandemic

EPA 2021
Consequenc
7:54

Consequences of COVID-19 Outbreak on Mental Health

EPA 2021
Obstetric
6:010

Obstetric Complications: The Forgotten Risk Factor for Schizophrenia

EPA 2021

Videos from category: Respiratory

Severe ast
8:04

Severe asthma guidelines: Update 2019

ERS 2019
Resetting
7:38

Resetting the agenda: a new approach to asthma in GINA 2019

ERS 2019
Personalis
5:14

Personalised medicine applied to inhaler selection

ERS 2019
Hot topics
3:58

Hot topics in respiratory medicine and science

ERS 2019

Suggested videos

By Author
By Topic
By Congress
7:07
KEYNOTE-024 5-year OS update: first-line (1L) pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) in patients (pts) with metastatic NSCLC and PD-L1 tumor proportion score (TPS) ≥50%
ESMO 2020
4:21
Highlights of the 17th St. Gallen International Breast Cancer Conference
St. Gallen BCC 2021
13:09
A Polypill for Primary Prevention of Cardiovascular Disease in Intermediate Risk People: Results of the International Polycap Study (TIPS)-3
AHA 2020
11:15
EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
ESC 2020
6:13
Breast cancer highlights from ESMO2020
ESMO 2020
11:06
IMpassion031: Results from a phase III study of neoadjuvant atezolizumab + chemotherapy in early triple-negative breast cancer
ESMO 2020
8:49
First safety and efficacy results of PRADO: A phase II study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in resectable stage III melanoma
ASCO 2020
15:58
2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease
ESC 2020
7:44
Summary of clinical and scientific topics discussed at EASD 2020 congress
EASD 2020
9:01
A Three-arm N-of-1 Trial With Statin, Placebo and Tablet Free Periods, to Verify Side Effects and Identify Their Cause: The SAMSON Trial
AHA 2020
16:51
Detailed summary of the Consensus Session of the SG-BCC 2021
St. Gallen BCC 2021
6:22
Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study
ASH 2019
14:31
ESC Gold Medal 2020 Winner: Kari Stefansson
ESC 2020
4:48
PRADA Trial: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol
ACC 2021
3:25
Single cell RNA seq of immune infiltrates
EADO 2019
8:42
Safety and efficacy of the oral JAK3/TEC inhibitor PF-06651600 and the oral TYK2/JAK1 inhibitor PF-06700841 in a withdrawal/retreatment extension study in patients with alopecia areata
EADV 2019
9:42
De-escalation of early breast cancer therapy: Umberto Veronesi’s legacy
St. Gallen BCC 2021
8:34
State of the Science: The Six Pillars of Heart Failure Therapy
AHA 2020
20:34
Triple negative breast cancer highlights in ESMO 2020
ESMO 2020
9:11
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
EHA 2020
8:34
Targeting Breast Cancer: Breaking the Code
ASCO 2019
17:43
Recognizing and Addressing Risk in Patients with HR-positive, HER2-negative Early Breast Cancer
St. Gallen BCC 2021
11:28
Effects of empagliflozin on physical activity and compensatory appetite responses in people with type 2 diabetes: the SEESAW trial
EASD 2020
6:46
The Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia
AHA 2020
7:02
Clinical Impact of Ibrutinib with R-CHOP in Untreated Non-GCB DLBCL Co-Expressing BCL2 and MYC Genes in the Phase 3 Phoenix Trial
ASH 2019
9:22
MONARCH-E trial: Abemaciclib reduces recurrence in HR+ high risk early breast cancer
ESMO 2020
13:01
Latest trends, developments in breast surgery
St. Gallen BCC 2021
7:33
2020 ESC Guidelines on Adult Congenital Heart Disease
ESC 2020
8:36
Why We Should Still Care about Glycemic Lowering Strategies for Type 2 Diabetes
EASD 2019
Search by Scientific Content
Search by Congress
Search:
Date
Filters:
Treatment
9:31
Title Description

Treatment of hematological malignancies in 2021

Presenter: Paolo Corradini
Hematology
EHA 2021
State of t
17:17
Title Description

State of the art treatment of breast cancer

Presenter: Jane Lowe Meisel
Oncology
ASCO 2021
Novelties
10:59
Title Description

Novelties in the treatment of chronic myeloid leukemia

Presenter: Giuseppe Saglio
Hematology
EHA 2021
Novelties
13:14
Title Description

Novelties in the treatment of follicular lymphoma

Presenter: Kai Hübel
Hematology
EHA 2021
Harnessing
10:06
Title Description

Harnessing the immune system in multiple myeloma: CAR T-cell therapy and bispecific antibodies

Presenter: Xavier Leleu
Hematology
EHA 2021
Results fr
5:00
Title Description

Results from the JAKARTA and JAKARTA2 trials

Presenter: Claire Harrison
Hematology
EHA 2021
Novelties
8:56
Title Description

Novelties on the treatment of Multiple Myeloma

Presenter: Mohamad Mohty
Hematology
EHA 2021
Response a
6:58
Title Description

Response and survival results up to five years from the KEYNOTE-052 phase 2 study

Presenter: Arjun Vasant Balar
Oncology
ASCO 2021
Expanded e
6:07
Title Description

Expanded efficacy and safety analyses from CheckMate 577

Presenter: Ronan Joseph Kelly
Oncology
ASCO 2021
IMpower010
5:36
Title Description

IMpower010: Primary results of a phase III global study of atezolizumab versus best supportive care after adjuvant chemotherapy in resected stage IB-IIIA non-small cell lung cancer

Presenter: Heather A. Wakelee
Oncology
ASCO 2021
Relatlimab
6:55
Title Description

Relatlimab plus nivolumab versus NIVO in first-line advanced melanoma: Primary phase III results from RELATIVITY-047

Presenter: Evan J. Lipson
Oncology
ASCO 2021
ODENZA: A
4:28
Title Description

ODENZA: A French prospective, randomized, open-label, multicenter, cross-over phase II trial of preference between darolutamide and enzalutamide in men with asymptomatic or mildly symptomatic metastatic castrate-resistant prostate cancer (CRPC).

Presenter: Emeline Colomba
Oncology
ASCO 2021
Effectiven
4:27
Title Description

Effectiveness and safety of apixaban versus warfarin in obese patients with nonvalvular atrial fibrillation enrolled in medicare and veteran affairs

Presenter: Steven B. Deitelzweig
Cardiology
ACC 2021
PRADA Tria
4:48
Title Description

PRADA Trial: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol

Presenter: Siri Lagethon Heck
Cardiology
ACC 2021
ADAPTABLE
5:09
Title Description

ADAPTABLE Study: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial

Presenter: William Schuyler Jones
Cardiology
ACC 2021
PARADISE-M
6:09
Title Description

PARADISE-MI: Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction

Presenter: Marc A. Pfeffer
Cardiology
ACC 2021

Lectures

Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology